GLOBALLY CONNECTED MEDICINAL CANNABIS GROUP
Health House International Limited was founded to pursue opportunities in the burgeoning global medicinal cannabis market.
Since 2014, the Board and founding shareholders of the Company have been pioneers in the Global medicinal cannabis sector establishing a number of publicly-listed companies including AusCann Group, Zelda Therapeutics and CannPal Animal Therapeutics.
Premium Quality Range – Products to view full range of products.
German company making cannabinoid medicine available for different patients and medical conditions in a range of oils.
An EU pharmaceutical licensed company, MGC Pharmaceuticals is driven by the goal to make Phytomedicines available in pharmacies and to patients in need, in the most cost-effective, consistent and efficient manner possible.
CanniMed was the very first producer licensed to sell medical cannabis in Canada.
Timeline: Towards a Legal Medicinal Cannabis Market
California passes Proposition 215. It becomes the first US state to legalise medicinal cannabis.
Portugal decriminalises the use of all drugs.
Canada passes the Medicinal Marijuana Access Program, which allows clinicians to prescribe medicinal cannabis.
Montana becomes tenth US state to legalise medicinal cannabis.
Israel approves the first government sanctioned cannabis growing operations.
Colorado & Washington
Colorado and Washington become the first two states to legalise the recreational use of cannabis.
UK-based GW Pharmaceuticals, listed on the AIM London market, dual lists on the US NASDAQ.
Canada introduces the Medical Purposes Regulations, which lets patients access the drug from licensed producers.
The Italian parliament signs a motion to legalise cannabis.
Canopy Growth becomes the first cannabis stock to list on the Toronto Stock Exchange.
Germany passes a law legalising the use of cannabis for medical purposes.
Israel announces it will exports of medicinal cannabis.
Sativa becomes the UK’s first medical cannabis investment vehicle to be listed on the NEX Exchange.
Poland votes in favour of legalising medicinal cannabis.
Canada’s Aurora Cannabis and CanniMed Therapeutics $3.2 billion merger becomes the industry’s biggest M&A deal.
Canada’s Cronos Group becomes the first cannabis company to list on the US NASDAQ.
UK Home Secretary Sajid Javid changes the classification of medicinal cannabis to Schedule 2.
Medicinal cannabis available on prescription in the UK.